Brian K. Beeler

This profile gathers the share dealings of Brian K. Beeler in Horizon Therapeutics Public Ltd Co, where the filings describe the role as senior executive. We count 5 filings; the first trade dates from 2 January 2016 and the latest from 17 September 2021.

Every open-market trade on record is a sale: 1 sale worth €2.6M. Outside the open market, there are 2 share grants and 2 option exercises. So far in 2021, the count stands at no purchases and 1 sale.

On 17 September 2021 came the latest disclosure, an open-market sale for €2.6M in Horizon Therapeutics Public Ltd Co. Filings reach the SEC (Form 4) feed a median of 3 days after the trade. For comparison, the SEC allows two business days to file a Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.